Company

We are guided and inspired by

our vision

About Royal Philips

 

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

Business highlights in Q1

Philips details plans to increase its hospital ventilator production to 4,000 units/week by Q3 2020.

Jackson Memorial Hospital gives Philips Enterprise Monitoring as a Service model high marks for satisfaction and efficiency.

Philips starts producing new Philips Respironics E30 ventilator to help free up ICU units in wake of COVID-19.

Philips results in Q3 2015

Philips in Q1 2020

Sales: EUR 4.2 bln

Adjusted EBITA: EUR 244 mln

Income from continuing operations: EUR 42 mln

Our transition towards a circular economy

Rethink the future

Changing the way we do business
Circular economy activities on Guardian Sustainable Business

Circular economy

Philips' transition to a circular economy
Annual report 2016

Annual Report 2019

Philips outlines its financial and sustainability performance in 2019